Stock RZLT REZOLUTE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Rezolute, Inc.

Equities

RZLT

US76200L3096

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
2.66 USD +2.31% Intraday chart for Rezolute, Inc. -22.45% +168.01%
Apr. 18 JonesTrading Starts Rezolute With Buy Rating, $10 Price Target MT
Mar. 06 Rezolute, Inc. Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia CI

Chart calendar Rezolute, Inc.

b11357c7678c16821c7ed053661eff78.n2QB9OfHsGjmvp69aggfVq-bkprjexwmLMz38lFFrQI.0TZvvpe2_zrT8PSEEzp1O9nv5PSFSXVQQZuewwM8nDbtLG2wpKHUAKCT2w~bfffa77af2102b7a1a4b06f4b4dda646

Upcoming events on Rezolute, Inc.

2024-05-04 01:15 pm Pediatric Endocrine Society Meeting - Abstract No : 6790
2024-05-13 Q3 2024 Earnings Release (Projected)
2024-09-11 Q4 2024 Earnings Release (Projected)
2024-11-06 Q1 2025 Earnings Release (Projected)
2025-02-04 Q2 2025 Earnings Release (Projected)

Past events on Rezolute, Inc.

2024-02-13 04:05 pm Q2 2024 Earnings Release
2023-11-27 02:30 pm BTIG Ophthalmology Day
2023-11-13 04:05 pm Q1 2024 Earnings Release
2023-09-26 02:10 pm Cantor Global Healthcare Conference
2023-09-14 04:05 pm Q4 2023 Earnings Release
2023-09-12 02:00 pm H.C. Wainwright Global Investment Conference
2023-06-27 04:30 pm RZ358 Phase3 Update Call
2023-05-25 06:00 pm Annual General Meeting
2023-05-11 04:05 pm Q3 2023 Earnings Release
2023-03-22 04:30 pm Investor Meeting - Key Opinion Leader
2023-02-10 04:05 pm Q2 2023 Earnings Release
2022-11-17 11:25 am Jefferies London Healthcare Conference
2022-11-09 04:05 pm Q1 2023 Earnings Release
2022-11-03 01:47 pm Retina Society Scientific Meeting
2022-09-15 04:05 pm FY 2022 Earnings Release
2022-09-15 08:55 am European Society for Paediatric Endocrinology Conference - Abstract Code FC3.2
2022-06-16 06:00 pm Annual General Meeting
2022-05-12 04:05 pm Q3 2022 Earnings Release
2022-05-04 04:30 pm Business Update Call
2022-05-01 02:30 pm RZ358 Phase 2b Study Results Call

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-25,9
-31,3
17.11%		0,00
0,00
- 		-22,9
-22,5
-1.68%		-41,8
-45,1
7.27%		-56,0
-60,0
6.65%
-65,1

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-30,4
-35,8
14.96%		0,00
0,00
- 		-20,9
-22,1
5.26%		-41,1
-46,7
12.08%		-51,8
-58,0
10.74%
-61,8

Net income
Million USD		Released
Forecast
Spread 		-30,4
-35,8
14.96%		-20,3
-21,8
6.73%		-20,9
-21,6
3.15%		-41,1
-46,7
12.08%		-51,8
-57,8
10.46%
-61,0

EPS
USD		Released
Forecast
Spread 		-18,5
-15,0
-23.33%		-3,54
-4,00
11.5%		-2,72
-2,82
3.63%		-2,26
-2,48
8.99%		-1,01
-1,22
17.35%
-1,12

Announcement Date10/09/1913/10/2015/09/2115/09/2214/09/23-

Quarterly results

Fiscal PeriodJune 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-12,1
-8,67
-40.21%		-10,8
-15,5
30.66%		-11,3
-14,6
22.58%		-10,2
-12,2
16.06%		-14,4
-15,5
7.41%		-17,1
-15,7
-8.84%		-14,2
-18,2
21.82%		-15,9
-16,5
3.52%		-15,2
-18,1
15.94%
-16,4


-17,4


-18,0


-19,2


-20,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-12,6
-8,98
-40.31%		-11,2
-16,2
30.67%		-9,42
-15,1
37.5%		-9,83
-12,4
20.86%		-13,6
-13,5
-0.27%		-15,7
-15,6
-0.51%		-12,7
-18,5
31.21%		-14,5
-16,4
11.25%		-13,9
-16,7
16.57%
-15,9


-16,4


-18,0


-19,2


-20,4

Net income
Million USD		Released
Forecast
Spread 		-12,6
-8,93
-41%		-11,2
-15,9
29.62%		-9,42
-15,1
37.5%		-9,83
-12,4
20.86%		-13,6
-13,5
-0.27%		-15,7
-15,6
-0.51%		-12,7
-18,5
31.21%		-14,5
-13,5
-7.86%		-13,9
-16,9
17.58%
-15,9


-16,4


-18,0


-19,2


-20,4

EPS
USD		Released
Forecast
Spread 		-0,80
-0,69
-16.28%		-0,65
-0,91
28.26%		-0,30
-0,56
45.95%		-0,19
-0,31
39.36%		-0,26
-0,32
18.24%		-0,30
-0,30
0%		-0,25
-0,36
29.78%		-0,28
-0,28
0.88%		-0,27
-0,29
6.9%
-0,30


-0,28


-0,32


-0,32


-0,29

Announcement Date09/02/2212/05/2215/09/2209/11/2210/02/2311/05/2314/09/2313/11/2313/02/24-----

Upcoming sector events for Rezolute, Inc.

2024-04-28 HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-30 04:05 pm EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Rezolute, Inc.

2024-04-25 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-25 REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-25 04:05 pm PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-25 06:30 am SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RZLT Stock
  4. Calendar Rezolute, Inc.